Connected Drug Delivery Devices Market 2021 Ongoing Trend, Recent Developments, Competitive Landscape and Regional Forecast to 2028


News provided by

Shibuya Data Count

Jan 05, 2022, 02:04 EST


Shibuya-ku, Tokyo, Japan, Japan, Jan 05, 2022, 02:04 /Comserve / -- The global market for connected drug delivery devices is valued at $1,119.3 million by 2027, surging from $189.4 million in 2018 at a noteworthy growth rate of 24.6%.

The global market for connected drug delivery devices is valued at $1,119.3 million by 2027, surging from $189.4 million in 2018 at a noteworthy growth rate of 24.6%.

Connected drug delivery is an emerging technology that helps in addressing people’s health issues regarding disease management protocols, medications, and treatments.

Impact Analysis of COVID-19 on Connected Drug Delivery Devices Market:

The unexpected situation created by COVID-19 across the countries has led to the lockdown of businesses for an uncertain period of time. The processes of industries like product manufacturing, inventory and logistics management are disrupted mainly because of the pandemic spread, which will eventually create a massive impact on the global industry. On the other hand, the COVID-19 outbreak may create a considerable impact on the global market for connected drug delivery devices. Notable industry players operating in the connected drug delivery technologies are implementing effective strategies to support the society, along with to strengthen their position worldwide. For example, in January 2020, Aptar Pharma, the U.S. based drug delivery systems company, teamed up with Lupin, leading multinational pharma venture to release ADHERO, connected drug delivery device for asthma and COPD (chronic obstructive pulmonary disease) patients in India. The device mainly helps to enhance the patient’s adherence to the prescribed therapy. These strategy implementations by market players amid the COVID-19 chaos may offer extensive opportunities for the global connected drug delivery devices market.

Get A PDF Sample For More Detailed Market Insights:- https://www.sdki.jp/sample-request-104976

The growing prevalence of chronic illnesses such as diabetes, COPD (chronic obstructive pulmonary disease), cancer, and asthma worldwide is expected to increase the demand for drugs and advanced medical devices, which will ultimately accelerate the global connected drug delivery market, during the forecast timeframe. Moreover, multiple ventures across the world, such as BD., LOG pharma, and AptarGroup Inc, are coming forward with the effective strategies to gain the trust of society. For example, in November 2019, LOG pharma, a leading company in the healthcare sector, has made an announcement to launch IoT-enabled ‘ActiveGuard’ smart device. This device is mainly designed to resolve the problem of a lack of patient adherence to prescribed medicines. These initiatives and technological upgradations may lead to bolster the global connected drug delivery devices market growth, in the analysis period.

The higher costs associated with connected drug delivery devices coupled with a lack of awareness among the people about the recent innovations may create a negative impact on the global industry, throughout the review period.

The integration of cutting-edge technologies in the connected drug delivery devices is expected to register significant revenue during the analysis timeframe. Market leaders involved in the global market are implementing the latest technologies to develop effective and cost-effective connected drug delivery devices. For example, in October 2018, Phillips-Medisize, a notable player in developing medical devices, has announced that they have released a ‘cloud-based data system’ especially for the drug delivery device manufacturers. These elements may lead to creating market opportunities for the global connected drug delivery devices market, in the future.

Based on the type the global market is mainly categorized into inhalation devices, injectable devices, and others. Injectable devices have a significant share and they are projected to generate a revenue of $652.2 million by 2027, increasing from $113.1 million in 2019. On the other hand, inhalation devices will have a rapid market and they are anticipated to generate a revenue of $467.1 million by 2027, rising from $76.3 million in 2019.

On the basis of technology, the global market for connected drug delivery devices is classified into Bluetooth, NFC, and others. The Bluetooth technology shall have substantial market share and it is projected to account for $733.0 million by 2027, with a rise from $122.8 million in 2019. However, the NFC technology will have exponential growth in the global industry and is anticipated to generate a revenue of $290.3 million, by 2027.

Depending on the end-user, the global connected drug delivery devices market is divided into hospitals and homecare settings. The hospital sub-segment will have a massive market share and is projected to generate a revenue of $805.8 million by 2027, surging from $141.6 million in 2019. Contrary to this, the homecare settings sub-segment will be the fastest-growing sub-segment and is predicted to register a revenue of $313.5 million by the end of 2027.

The connected drug delivery devices’ market for the Asia-Pacific region is projected to increase at a growth rate of 26.3% by registering revenue of $190.3 million by 2027. However, North America connected drug delivery devices market registered a revenue of $78.9 million in 2019 and it is estimated to reach upto $436.5 million by 2027.

Get A PDF Sample For More Detailed Market Insights:- https://www.sdki.jp/sample-request-104976

The leading global connected drug delivery devices market players consist of BD, Adherium, propeller Health, Proteus Digital Health, F. Hoffmann-La Roche Ltd, AptarGroup Inc. West Pharmaceutical Services, Syncro Technology Corp., Cohero Health, Inc., and Ypsomed AG. The connected drug delivery devices market leaders are following strategies such as product innovation and their launching, capacity expansions, and strategic tie-ups.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.


For more information, please contact:

Lauren Brown

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 50 50509159

Related Links
https://www.sdki.us/



Also from this source



Liquid Filtration Market - Global Forecast to 2023

This detailed analysis includes market size and forecasts, covering regional analysis, trends, oppor